Format

Send to

Choose Destination
J Dermatolog Treat. 2007;18(4):246-8.

Systemic corticosteroids for the outpatient treatment of necrobiosis lipoidica in a diabetic patient.

Author information

1
Department of Dermatology, Addenbrooke's Hospital NHS Trust, Cambridge, United Kingdom. eunicetan@doctors.org.uk

Abstract

Necrobiosis lipoidica (NL) remains a major therapeutic challenge for the dermatologist and diabetologist. Amongst many treatment modalities attempted, systemic corticosteroids remain controversial, not least because a proportion of NL patients are diabetic, and corticosteroids are likely to destabilize their diabetic control. Close supervision as an inpatient is often required. We report the ambulatory outpatient management of an insulin-dependent diabetic with ulcerated necrobiosis lipoidica complicated by activated protein C resistance.

PMID:
17671885
DOI:
10.1080/09546630701308294
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center